Altimmune
ALT
#7355
Rank
โ‚ฌ0.51 B
Marketcap
2,63ย โ‚ฌ
Share price
-0.42%
Change (1 day)
-9.56%
Change (1 year)

Earnings for Altimmune (ALT)

Earnings in 2026 (TTM): -โ‚ฌ77.78 Million

According to Altimmune's latest financial reports the company's current earnings are โ‚ฌ0.03 Million. In 2025 the company made an earning of -โ‚ฌ76.91 Million, an increase over its 2024 earnings that were of -โ‚ฌ82.35 Million. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Altimmune from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -โ‚ฌ77.78 Million1.13%
2025 -โ‚ฌ76.91 Million-6.61%
2024 -โ‚ฌ82.35 Million7.48%
2023 -โ‚ฌ76.63 Million4.17%
2022 -โ‚ฌ73.56 Million-12.55%
2021 -โ‚ฌ84.11 Million78.27%
2020 -โ‚ฌ47.18 Million164.65%
2019 -โ‚ฌ17.83 Million-54.59%
2018 -โ‚ฌ39.27 Million-12.95%
2017 -โ‚ฌ45.11 Million-164.04%
2016 โ‚ฌ70.43 M-2506.1%
2015 -โ‚ฌ2.93 Million-65.85%
2014 -โ‚ฌ8.58 Million-15.12%
2013 -โ‚ฌ10.1 Million146.72%
2012 -โ‚ฌ4.1 Million-16.07%
2011 -โ‚ฌ4.88 Million-76.1%
2010 -โ‚ฌ20.41 Million-8.89%
2009 -โ‚ฌ22.4 Million31.17%
2008 -โ‚ฌ17.08 Million549.91%
2007 -โ‚ฌ2.63 Million7.52%
2006 -โ‚ฌ2.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-โ‚ฌ0.2 Billion 151.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-โ‚ฌ15.73 Million-80.07%๐Ÿ‡บ๐Ÿ‡ธ USA